Pancreatic Cancer Research

ResearcherInha UniversityNo recent work listed

Ji Eun Lee

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7386-0015; OpenAlex author ID A5100347351. Sources: OpenAlex.

Their work

Papers
5 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
10
Papers, trials and grants by year

2017: 1 paper · 2018: 3 papers · 2019: none · 2020: none · 2021: 1 paper

Papers 5

  1. Intracellular KRAS-specific antibody enhances the anti-tumor efficacy of gemcitabine in pancreatic cancer by inducing endosomal escape. Co-author DOI 10.1016/j.canlet.2021.03.015↗
  2. A novel tropomyosin-related kinase A inhibitor, KK5101 to treat pancreatic cancer. Co-author DOI 10.1016/j.canlet.2018.03.041↗
  3. KRAS targeting antibody synergizes anti-cancer activity of gemcitabine against pancreatic cancer. First author DOI 10.1016/j.canlet.2018.09.013↗
  4. Melatonin Synergizes with Sorafenib to Suppress Pancreatic Cancer via Melatonin Receptor and PDGFR-β/STAT3 Pathway. Co-author DOI 10.1159/000491058↗
  5. Radiosensitization of the PI3K inhibitor HS-173 through reduction of DNA damage repair in pancreatic cancer. Co-author DOI 10.18632/oncotarget.22850↗

Closest collaborators

The 10 strongest of 10 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Jung Hee Park · 5 shared papers, 2017–2021 · strength 0.38
  2. Zhenghuan Fang · 5 shared papers, 2017–2021 · strength 0.38
  3. Hong Hua Yan · 5 shared papers, 2017–2021 · strength 0.38
  4. Kyung Hee Jung · 5 shared papers, 2017–2021 · strength 0.38
  5. Yeo Wool Kang · 5 shared papers, 2017–2021 · strength 0.38
  6. Soon‐Sun Hong · 4 shared papers, 2017–2021 · strength 0.30
  7. Mi Kwon Son · 3 shared papers, 2017–2021 · strength 0.24
  8. Yong‐Sung Kim · 2 shared papers, 2018–2021 · strength 0.17
  9. Soon Sun Hong · 1 shared paper, 2018 · strength 0.08
  10. Marufa Rumman · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.